Pseudovitelliform Macular Dystrophy and Pigment Dispersion Syndrome: Are They Related?
##plugins.themes.bootstrap3.article.main##
Pseudovitelliform macular dystrophy (PVMD) and pigment dispersion syndrome (PDS) are benign diseases that can evolve to a very severe stage. It is very rare to encounter both diseases in the same patient. We report a 42-year-old patient that presented a blurry vision. The anterior and posterior segment examination found pseudovitelliform macular degeneration associated with pigment dispersion syndrome. No other case was reported in the literature.
The physiopathology and the location of the two diseases are very different. Both pathologies are frequently benign. A combination of them should be considered a risk for the patient.
More cases of the two diseases should be reported to the literature if found and it could maybe lead to a link between them.
Downloads
Introduction
The pigment dispersion syndrome (PDS) and pseudovitelliform macular degeneration (PVMD) are two separate entities.
PDS is an abnormal concavity of the iris which is in contact with the ciliary band [1], [2] and causes pigment dispersion in the posterior and anterior chambers.
PDS can be complicated by pigmentary glaucoma (PG): the pigment obstructs the trabecular meshwork which rises the intraocular pressure (IOP) and causes nerve damage.
We estimate that 1%–1.5% of glaucoma cases in Caucasian countries are PDS causing PD [3].
On the other hand, PVMD is a very rare genetic macular disease caused by an accumulation of lipofuscin within the subretinal space [4].
PVMD and PDS are benign diseases that can evolve to a very severe stage. It is very rare to encounter both diseases in the same patient, and no case was reported in the literature.
We report a case of pseudovitelliform macular degeneration associated with pigment dispersion syndrome.
Case Report
A 42-year-old male presented to the hospital for blurry vision, and headaches. The refraction was –0.25 (–0.25 at 100°) in the right eye and (–0.25 at 5°) in the left eye with a 10/10 visual acuity. Intraocular pressure was 16 for both eyes. The anterior segment exam was notable for Krukenberg spindles on both sides (iris pigments in the inner layer of the cornea) (Fig. 1).
Fig. 1. Krukenberg spindle on slit lamp examination.
Gonioscopy showed an open angle (Schaffer stage 4) very pigmented with a Sampaolesi line and a posterior concavity of the iris (Fig. 2).
Fig. 2. Open angle (Schaffer IV) on gonioscopy.
The anterior segment OCT shows a posteriorly bowed iris towards the zonula and posterior chamber (Fig. 3).
Fig. 3. Anterior OCT showing a concave iris.
Retina examination showed a normal cup/disc ratio (4/10 symmetric) with an abnormal yellow reflect of the macula region in both sides (Fig. 4).
Fig. 4. Retinography of both eyes showing a yellowish lesion on the macular region.
On autofluorescence, there was a hyperfluorescent lesion of the macula region (Fig. 5).
Fig. 5. Hyper auto fluorescent lesion on the macula.
In fluorescein angiography, we find a diffusion in the fovea during all times of the examination (Fig. 6).
Fig. 6. Fovea diffusion during fluorescein angiography.
On OCT there was a material accumulation under the foveal depression between the retinal layers and an irregular pigment epithelium (Fig. 7).
Fig. 7. OCT of the macula showing a vitelliform accumulation under the retinal layers.
RNFL analysis showed suspicious temporo-inferior damage to the nerve fibers of the right eye, and supero-temporal damages on the left eye. Ganglion cell analysis was normal in both eyes.
With all these findings, the diagnosis of PDS and PVMD was retained.
The treatment consisted of performing a peripheral iridotomy in both irises, and monitoring.
During follow-up no progression of the disease occurred, and we found no evidence of complication or visual loss.
Discussion
Pigment Dispersion Syndrome
PDS occurs in patients between 20 and 40 years of age.
In the literature, reports of the risk of developing PG from PDS are estimated as between 35% and 50% [3].
Interestingly, congenital abnormalities due to mesodermal migration have been suggested to have a role in the development of PDS/PG [5], and a genetic anomaly occurring in the third trimester seems to be generally accepted as an etiological factor of PDS and PG [6].
Authors hypothesized that mutation of the LOXL1 gene could lead to defects of the stromal elastic fibers of the iris [7].
PDS has been reported as an autosomal dominant disease [8] Familial aggregation is a characteristic of PDS.
Unspecified, multiple genes coupled with environmental influences can cause these conditions [9]. Chromosome 7q35-q36 may be related to or increases the risk for PDS [8].
In 1970, Campbell discovered a direct correlation between the extent and position of iris transillumination defects and bundles of zonules that were inserted into the anterior surface of the lens in PDS [10]. It was proposed that frequent friction caused by iris movements led to pigment dispersion and iris transillumination [11], [12]. The typical location and proximity of the zonular bundles to the mid-peripheral iris and transillumination defects indicated that these bundles were responsible for the loss of pigment from the posterior iris [13]. Campbell also reported a characteristic backward bowing of the iris [10]. Moroi et al. [14] suggested an alternative mechanism associated with elongated anterior zonules centrally inserted on the anterior lens capsule, which could damage the iris pigment epithelium and cause pigment dispersion. A congenital posterior insertion of the iris has also been identified as a distinctive feature of PDS [15].
Pigment spreads in the anterior segment through aqueous humour and then accumulates in the trabecular meshwork on the posterior side of the cornea as Krukenberg spindles and on the anterior surface of the lens.
Pigment buildup can also be observed as a dark line on Schwalbe’s line. Detailed studies at the microscopic level have demonstrated the presence of pigmented epithelial melanosomes within the trabecular meshwork, as well as melanin inside the trabecular cells, indicating their ability to engulf and digest pigment [16], [17]. The Krukenberg spindle, a distinctive feature, is not caused by loose pigment cells sticking to the cornea. Instead, it results from pigment cells that have been engulfed by the endothelium [12], [18].
A patient with PDS may refer symptoms of headache and sporadic blurry vision, especially in the context of extreme physical activity [19].
In PDS, increases in intraocular pressure (IOP) typically range around 30 mmHg. However, occasional instances of more pronounced surges in IOP can occur, which coincide with episodes of pigment discharge and swelling of the cornea [3], [20], [21].
Slit lamp examination shows iris transillumination (Fig. 8) defects and Krukenberg spindle [22].
Fig. 8. Peripheral iris defects during transillumination [22].
Increased depth both in the central and peripheral areas during anterior chamber examination [23].
In gonioscopy, the trabecular meshwork is typically very pigmented at 360° with more intense pigmentation in the inferior part caused by gravity force. The Sampaolesi line is a pigmented line located in the inferior part of the chamber angle anterior to Schwalbe’s ring. It is not exclusive to PDS but is frequently found during examination [24].
Fundus examination can find glaucomatous optic nerve neuropathy in case of evolution to PG.
OCT allows early diagnosis of glaucoma by showing a decrease in the thickness of the retinal nerve fiber layer and ganglion cells [25].
Arigfoglu and al conducted a study involving 102 patients, employing SD-OCT (Spectral Domain Optical Coherence Tomography) and visual field analysis. Their findings revealed a reduced average thickness of the retinal nerve fiber layer in patients with PG compared to PDS. Additionally, they observed that the superior and inferior ganglion cell complex exhibited a thinner profile in PG eyes. As a result, the authors concluded that assessing the thickness of the retinal nerve fiber layer and ganglion cell complex using SD-OCT could serve as a valuable parameter for distinguishing between PG and PDS [26].
Beta-blockers, alpha-agonists, carbonic anhydrase inhibitors, and prostaglandins are the main treatment for IOP elevation.
Yag laser iridotomy consists in creating an orifice in the iris to balance the pressure between the anterior and posterior chambers. It helps flatten the iris and prevent contact with the zonular fibers. However, the iridotomy is still under debate as if it helps prevent the progression of PDS to PG.
Pseudovitelliform Macular Dystrophy
PVD is characterized by the deposit of a yellow material in the macular region [27]. The yellow appearance is a result of a particular amount of accumulated loose lipofuscin and photoreceptor debris [4].
It had been described for the first time in 1974 by Gass [28]. This lesion is found in a very heterogeneous family of pathologies some are known as the “pattern dystrophies” [29] and others are acquired known as “acquired vitelliform macular degeneration” (AVMD) [30].
The PVMD is an inherited autosomal dominant disease [27]. Mutations in the peripherin/RDS gene are a frequent cause of PD [31], 15 mutations of the gene have been described [32]. The gene codes for the peripherin/ RDS protein which has a key role in the formation and renewal of the discs in the rod and cone photoreceptors outer segment. These structures are essential for phototransduction [33].
Considerable phenotypic variability families had been reported [34].
PVMD is distinguished by the existence of horizontally oval macular lesions that are about one-third the size of a disc, displaying a clearly defined border and appearing grayish yellow in color. While smaller than the vitelliform lesions observed in Best’s disease (BD), they exhibit a remarkable similarity in their coloration [27].
The classical appearance of BD is the single, bilateral symmetrical egg yolk-like (vitelliform) lesion at the fovea [35] (Fig. 9).
Fig. 9. Autofluorescence of a vitelliform dystrophy in a best disease case [35].
BD is the principal differential diagnosis of pseudovitelliform dystrophy, but it most commonly affecting a juvenile population.
The diagnosis of PVMD can be challenging there is not a single diagnostic test or imaging modality that can provide a definitive diagnosis [30].
Macular OCT, fluorescein angiography and autofluorescence can help to orientate and assess the diagnosis.
Fluorescein angiography shows generally a leakage during the late phases of the exam.
It was believed that the presence of autofluorescence in the ocular fundus was solely due to lipofuscin in the retinal pigment epithelium (RPE). However, it has now been recognized that the autofluorescent material in the RPE comes from indigestible components of photoreceptor outer segments that have been phagocytized [36]. Additionally, autofluorescence also occurs within photoreceptor outer segments themselves [36].
In the OCT image, one can observe that the lesion is typically found within the subretinal space, situated between the retinal pigment epithelium (RPE) and the neurosensory retina. [37].
Till today, there is no proven and efficient treatment of this disease. Some authors suggest anti-VEGF injections however, the effect of anti-VEGF on these lesions remains uncertain, and the existing body of literature does not present a unanimous agreement regarding their advantages in this disease [30].
The other option is to monitor closely the patient and is the most privileged choice.
PVMD is identified by mild visual impairments affecting both eyes, with a noticeable lack of significant deterioration in vision or extremely slow progression of visual loss [27].
However, there is a range of perspectives regarding the impact of PD on visual disability. Some authors argue that PD primarily leads to mild visual impairment [38], [39]. But there are also reports of families where visual loss appears to be more pronounced [40], [41]. The prognosis is not necessarily benign, and Progression often results in significant impairment and legal blindness in its advanced stages [29].
Synthesis
Certainly, the two diseases have a genetic origin but the genes responsible are not the same and no evident connection has been found. Loxl1 which is muted in the PDS is located on the 15th chromosome, meanwhile, the peripherin/RDS also known as the PRPH2 gene is located on the 6th chromosome.
The peripherin/RDS gene mutation is found in a minority of patients diagnosed with pattern dystrophies [31]. The mutation has also been identified in other retinal diseases such as retinitis pigmentosa, cone-rod dystrophy, areolar choroidal dystrophy, and punctata albescens [31]. The gene mutation is not specific to pseudovitelliform dystrophy.
We can assess that PVMD has a multi genetic mutation origin, not only peripherin/RDS gene is involved. Other genes can certainly be found causing this disease. Maybe there is a common gene between PVMD and PDS that is not identified yet.
More genetic studies are needed for these two pathologies, and the Lox11 gene should also be studied in PVMD disease, it can be linked to it.
Conclusion
The physiopathology of the two diseases has not yet been fully elucidated and the location of the two diseases are very different.
PDS is an anterior segment disease with findings on the cornea, the irido-corneal angle, and the lens meanwhile PVMD touches the outer layer of the retina specifically in the macular region. Both pathologies are frequently benign, but in some cases, they can become severe, moreover, a combination of them should be considered a risk for the patient, and close monitoring should be started.
Until today there is no relation found between them and no other case has been reported in the literature.
A very careful fundus exam of patients with PDS can maybe reveal a pseudovitelliform lesion, and an anterior segment exam with gonioscopy could reveal PDS in patients known to have PVMD. This is why a complete ophthalmologic examination should be done in any case and can lead to new findings.
More cases of the two diseases should be reported to the literature if found and it could maybe lead to a link between them.
Other genetic studies should be done for the two diseases than can lead to a common gene mutation.
References
-
Flügel-Koch CM, Tektas OY, Kaufman PL, Paulsen FP, Lütjen-Drecoll E. Morphological alterations within the peripheral fixation of the iris dilator muscle in eyes with pigmentary glaucoma. Invest Ophthalmol Vis Sci. 2014 Jun 17;55(7):4541–51.
DOI |
Google Scholar
1
-
Klingenstein A, Kernt M, Seidensticker F, Kampik A, Hirneiss C. Anterior-segment morphology and corneal biomechanical characteristics in pigmentary glaucoma. Clin Ophthalmol. 2014;8:119–26.
DOI |
Google Scholar
2
-
Niyadurupula N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma—A major review. Clin Exp Ophthalmol. 2008;38:868–82.
DOI |
Google Scholar
3
-
Arnold JJ, Sarks JP, Killingsworth MC, Kettle EK, Sarks SH. Adult vitelliform macular degeneration: a clinicopathological study. Eye. 2003;17:717–26.
DOI |
Google Scholar
4
-
Rodrigues MM, Spaeth GL, Weinreb S, Sivalingam E. Spectrum of trabecular pigmentation in open-angle glaucoma: a clinicopathologic study. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976 Mar–Apr;81(2):258–76.
Google Scholar
5
-
Kingsley O, Vinod K, Gedde SJ. Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol. 2017;28:154–60.
DOI |
Google Scholar
6
-
Giardina E, Oddone F, Lepre T, Centofanti M, Peconi C, Tanga L, et al. Common sequence variants in the LOXL1 gene in pigment dispersion syndrome and pigmentary glaucoma.BMCOphthalmol. 2014 Apr 16;14:52.
DOI |
Google Scholar
7
-
Andersen JS, Pralea AM, del Bono EA, Haines JL, Gorin MB, Schuman JS, et al. A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol. 1997 Mar;115(3):384–8.
DOI |
Google Scholar
8
-
Sugar HS. Concerning the chamber angle. I Gonioscopy Am J Ophthalmol. 1940;23:853–66.
DOI |
Google Scholar
9
-
Campbell DG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol. 1979;97:1667–72.
DOI |
Google Scholar
10
-
Korobova V. On the etiology of Krukenberg’s spindle. Russkii Ophth J. 1929;12:476–84.
Google Scholar
11
-
Lehto I, Ruusuvaara P, Setala K. Corneal endothelium in pigmentary glaucoma and pigment dispersion syndrome. Acta Ophthalmol (Copenh). 1990;68:703–9.
DOI |
Google Scholar
12
-
Evans WE, Odom RE, Weenas EJ. Krukengerg’s spindle: a study of 202 collected cases. Arch Ophthalmol. 1941;26:1023–56.
DOI |
Google Scholar
13
-
Moroi SE, Lark KK, Sieving PA, Nouri-Mahdavi K, Schlötzer Schrehardt U, Katz GJ, et al. Long anterior zonules and pigment dispersion. Am J Ophthalmol. 2003 Dec;136(6):1176–8.
DOI |
Google Scholar
14
-
Sokol J, Stegman Z, Liebmann JM, Ritch R. Location of the iris insertion in pigment dispersion syndrome. Ophthalmology. 1996;103:289–93.
DOI |
Google Scholar
15
-
Kupfer C, Kuwabara T, Kaiser-Kupfer M. The histopathology of pigmentary dispersion syndromewith glaucoma.AmJOphthalmol. 1975;80:857–62.
DOI |
Google Scholar
16
-
Richardson TM, Hutchinson BT, Grant WM. The outflow tract in pigmentary glaucoma: a light and electron microscopic study. Arch Ophthalmol. 1977;95:1015–25.
DOI |
Google Scholar
17
-
Shimizu T, Hara K, Futa R. Fine structure of trabecular meshwork and iris in pigmentary glaucoma. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981;215(3):171–80.
DOI |
Google Scholar
18
-
Haynes WL, Johnson AT, Alward WL. Inhibition of exercise induced pigment dispersion in a patient with pigmentary dispersion syndrome. Am J Ophthalmol. 1990;109:601–2.
DOI |
Google Scholar
19
-
Regine F, Scuderi GL, Cesareo M, Ricci F, Cedrone C, Nucci C. Validity and limitations of the Nidek NT-4000 noncontact tonometer: a clinical study. Ophthalmic Physiol Opt. 2006 Jan;26(1):33–9.
DOI |
Google Scholar
20
-
Scuderi GL, Cascone NC, Regine F, Perdicchi A, Cerulli A, Recupero SM. Validity and limitations of the rebound tonometer (ICare®): clinical study. Eur J Ophthalmol. 2011 May–Jun;21(3):251–7.
DOI |
Google Scholar
21
-
Perone JM, Chaussard D, Hayek G. Bilateral acute iris transillumination (BAIT) syndrome: literature review. Clin Ophthalmol. 2019 Jun 5;13:935–43.
DOI |
Google Scholar
22
-
Davidson JA, Brubaker RF, Ilstrup DM. Dimen-sions of the anterior chamber in pigment dispersion syn-drome. Arch Ophthalmol. 1983;101:81–3.
DOI |
Google Scholar
23
-
Scuderi G, Contestabile MT, Scuderi L, Librando A, Fenicia V, Rahimi S. Pigment dispersion syndrome and pigmentary glaucoma: a review and update. Int Ophthalmol. 2019 Jul;39(7):1651–62.
DOI |
Google Scholar
24
-
Abdolrahimzadeh S, Parisi F, Scavella V, Recupero SM. Optical coherence tomography evidence on the correlation of choroidal thickness and age with vascular-ized retinal layers in normal eyes. Retina. 2016 Apr;36:2329–38.
DOI |
Google Scholar
25
-
Arifoglu HB, Simavli H, Midillioglu I, Berk Ergun S, Simsek S. Comparison of ganglion cell and retinal nerve fiber layer thickness in pigment dispersion syndrome, pigmentary glaucoma, and healthy subjects with spectral-domain OCT. Semin Ophthalmol. 2017;32(2):204–9.
DOI |
Google Scholar
26
-
Hodes BL, Feiner LA, Sherman SH, Cunningham D. Progression of pseudovitelliform macular dystrophy. Arch Ophthalmol. 1984 Mar;102(3):381–3.
DOI |
Google Scholar
27
-
Gass JDM. A clinicopathologic study of a peculiar foveomacular dystrophy. Trans Am Ophthalmol Soc. 1974;73:139–55.
Google Scholar
28
-
Francis PJ, Schultz DW, Gregory AM, Schain MB, Barra R, Majewski J, et al. Genetic and phenotypic heterogeneity in pattern dystrophy. Br J Ophthalmol. 2005 Sep;89(9):1115–9.
DOI |
Google Scholar
29
-
Juliano J, Patel S, Ameri H Md. Acquired vitelliform macular degeneration: characteristics and challenges of managing subretinal fluid. J Ophthalmic Vis Res. 2021 Oct 25;16(4):582–91.
DOI |
Google Scholar
30
-
Grover S, Fishman GA, Stone EM. Atypical presentation of pattern dystrophy in two families with peripherin/RDS mutations. Ophthalmology. 2002;109:1110–17.
DOI |
Google Scholar
31
-
Boon CJ, van Schooneveld MJ, den Hollander AI, van Lith-Verhoeven JJ, Zonneveld-VrielingMN, Theelen T, et al. Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus. Br J Ophthalmol. 2007 Nov;91(11):1504–11.
DOI |
Google Scholar
32
-
Boon CJ, den Hollander AI, Hoyng CB, Cremers FP, Klevering BJ, Keunen JE. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res. 2008 Mar;27(2):213–35.
DOI |
Google Scholar
33
-
Aaberg TM, Han DP. Evaluation of phenotypic similarities between stargardt flavimaculatus and retinal pigment epithelial pattern dystrophies. Trans Am Ophthalmol Soc. 1987;85:101–19.
Google Scholar
34
-
Rahman N, Georgiou M, Khan KN, Michaelides M. Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options. Br J Ophthalmol. 2020 Apr;104(4):451–60.
DOI |
Google Scholar
35
-
Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology. 2006 Aug;113(8):1392–400.
DOI |
Google Scholar
36
-
BenhamouN,Messas-Kaplan A, CohenY,Gaudric A, Souied EH, Soubrane G, et al. Adult-onset foveomacular vitelliform dystrophy with OCT 3. Am J Ophthalmol. 2004;138:294–6.
DOI |
Google Scholar
37
-
Saatci AO, Yasti ZO, Köse S, Memi¸soglu B. Butterfly-like pattern dystrophy and unilateral choroidal neovascularization. Acta Ophthalmol Scand. 1998 Dec;76(6):734–6.
DOI |
Google Scholar
38
-
Sabates R, Pruett R, Hirose T. Pseudovitelliform macular degeneration. Retina. 1982;2:197–205.
DOI |
Google Scholar
39
-
Marmor MF, McNamara JA. Pattern dystrophy of the retinal pigment epithelium and geographic atrophy of the macula. Am J Ophthalmol. 1996;122:382–92.
DOI |
Google Scholar
40
-
Yang Z, Lin W, Moshfeghi DM, Thirumalaichary S, Li X, Jiang L, et al. A novel mutation in the RDS/peripherin gene causes adult-onset foveomacular dystrophy.AmJOphthalmol. 2003 Feb;135(2):213–18.
DOI |
Google Scholar
41
Most read articles by the same author(s)
-
Mehdi Khamaily,
Othman Haddani,
Loubna Mouhib,
Amine Razzak,
Mohamed Bouazza,
Mohamed Elbelhadji,
Dehydrated Amniotic Membrane in Pterygium Surgery , European Journal of Medical and Health Sciences: Vol. 6 No. 3 (2024) -
Idriss Maarouf,
Mehdi Khamaily,
Othman Haddani,
Loubna Mouhib,
Mohamed Elbelhadji,
Combined Argon and Yag Laser Puppiloplasty: A Case Report , European Journal of Medical and Health Sciences: Vol. 7 No. 2 (2025)